Abrocitinib: First Approval (vol 81, pg 2149, 2021)

被引：0

作者：

Deeks, Emma D. ^{[1
]}

Duggan, Sean ^{[1
]}

机构：

[1] Springer Nat, Private Bag 65901, Auckland 0754, New Zealand

来源：

关键词：

D O I：

10.1007/s40265-022-01694-3

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：609 / 609

页数：1

共 50 条

[21] Daridorexant: First Approval (vol 82, pg 601, 2022)
Markham, Anthony
DRUGS, 2022, 82 (07) : 841 - 841
[22] Zavegepant: First Approval (vol 83, pg 825, 2023)
Dhillon, Sohita
DRUGS, 2023,
[23] Filgotinib: First Approval (vol 80, pg 1987, 2020)
Dhillon, Sohita
Keam, Susan J.
DRUGS, 2021, 81 (02) : 297 - 297
[24] Vorasidenib: First Approval (vol 84, pg 1325, 2024)
Lamb, Yvette N.
DRUGS, 2024, 84 (12) : 1673 - 1673
[25] Zastaprazan: First Approval (vol 84, pg 863, 2024)
Blair, Hannah A.
DRUGS, 2024, 84 (10) : 1333 - 1333
[26] Concizumab: First Approval (vol 83, pg 1053, 2023)
Keam, Susan J.
DRUGS, 2023, 83 (13) : 1253 - 1254
[27] Oliceridine: First Approval (vol 80, pg 1739, 2020)
Markham, Anthony
DRUGS, 2020, 80 (17) : 1871 - 1871
[28] Zilucoplan: First Approval (vol 84, pg 99, 2023)
Shirley, Matt
DRUGS, 2024, 84 (03) : 373 - 373
[29] Ritlecitinib: First Approval (vol 83, pg 1315, 2023)
Blair, Hannah A.
DRUGS, 2023, 83 (15) : 1457 - 1457
[30] Selpercatinib: First Approval (vol 80, pg 1119, 2020)
Markham, Anthony
DRUGS, 2021, 81 (01) : 181 - 181